The contrasting evidence on Notch1 inhibition in combination with doxorubicin may be explained by the ambiguous role of Notch1 in HCC progression which can assume either an oncogenic or oncosuppressive function, whereas Notch3 seems to be more concordantly pro-tumoral. Here, NOTCH3 is linked to hepatocellular carcinoma.